AllianceBernstein’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$870K Buy
238,930
+186,660
+357% +$679K ﹤0.01% 2367
2025
Q1
$100K Sell
52,270
-25,370
-33% -$48.7K ﹤0.01% 3068
2024
Q4
$148K Hold
77,640
﹤0.01% 3076
2024
Q3
$102K Hold
77,640
﹤0.01% 3130
2024
Q2
$79.2K Buy
+77,640
New +$79.2K ﹤0.01% 3146
2022
Q2
Sell
-150,335
Closed -$108K 3255
2022
Q1
$108K Buy
150,335
+700
+0.5% +$503 ﹤0.01% 3096
2021
Q4
$338K Hold
149,635
﹤0.01% 2899
2021
Q3
$431K Hold
149,635
﹤0.01% 2801
2021
Q2
$567K Buy
149,635
+82,800
+124% +$314K ﹤0.01% 2749
2021
Q1
$226K Hold
66,835
﹤0.01% 3002
2020
Q4
$187K Sell
66,835
-107,171
-62% -$300K ﹤0.01% 2998
2020
Q3
$437K Sell
174,006
-4,300
-2% -$10.8K ﹤0.01% 2584
2020
Q2
$2.42M Buy
178,306
+55,487
+45% +$753K ﹤0.01% 1731
2020
Q1
$931K Hold
122,819
﹤0.01% 2057
2019
Q4
$776K Hold
122,819
﹤0.01% 2371
2019
Q3
$481K Hold
122,819
﹤0.01% 2558
2019
Q2
$594K Buy
122,819
+9,000
+8% +$43.5K ﹤0.01% 2525
2019
Q1
$932K Buy
113,819
+4,399
+4% +$36K ﹤0.01% 2261
2018
Q4
$605K Buy
109,420
+57,620
+111% +$319K ﹤0.01% 2390
2018
Q3
$457K Hold
51,800
﹤0.01% 2649
2018
Q2
$517K Buy
51,800
+8,600
+20% +$85.8K ﹤0.01% 2588
2018
Q1
$412K Hold
43,200
﹤0.01% 2569
2017
Q4
$642K Hold
43,200
﹤0.01% 2454
2017
Q3
$850K Hold
43,200
﹤0.01% 2344
2017
Q2
$621K Buy
43,200
+26,400
+157% +$380K ﹤0.01% 2508
2017
Q1
$155K Hold
16,800
﹤0.01% 2875
2016
Q4
$175K Buy
16,800
+1,600
+11% +$16.7K ﹤0.01% 2892
2016
Q3
$138K Buy
15,200
+1,100
+8% +$9.99K ﹤0.01% 2893
2016
Q2
$105K Buy
+14,100
New +$105K ﹤0.01% 2894
2015
Q2
Sell
-2,300
Closed -$26K 2991
2015
Q1
$26K Hold
2,300
﹤0.01% 3215
2014
Q4
$27K Sell
2,300
-1,300
-36% -$15.3K ﹤0.01% 3178
2014
Q3
$80K Hold
3,600
﹤0.01% 2996
2014
Q2
$100K Buy
+3,600
New +$100K ﹤0.01% 2984